JP6846106B2 - Ｄｋｋ１発現促進剤および美白剤 - Google Patents
Ｄｋｋ１発現促進剤および美白剤 Download PDFInfo
- Publication number
- JP6846106B2 JP6846106B2 JP2015174214A JP2015174214A JP6846106B2 JP 6846106 B2 JP6846106 B2 JP 6846106B2 JP 2015174214 A JP2015174214 A JP 2015174214A JP 2015174214 A JP2015174214 A JP 2015174214A JP 6846106 B2 JP6846106 B2 JP 6846106B2
- Authority
- JP
- Japan
- Prior art keywords
- dkk1
- extract
- expression
- whitening agent
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102100030074 Dickkopf-related protein 1 Human genes 0.000 title claims description 60
- 101000864646 Homo sapiens Dickkopf-related protein 1 Proteins 0.000 title claims description 59
- 230000002087 whitening effect Effects 0.000 title claims description 26
- 239000000284 extract Substances 0.000 claims description 33
- 244000144730 Amygdalus persica Species 0.000 claims description 21
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 21
- 239000004480 active ingredient Substances 0.000 claims description 15
- 230000009471 action Effects 0.000 claims description 8
- 210000004207 dermis Anatomy 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 description 36
- 241000202807 Glycyrrhiza Species 0.000 description 29
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 28
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 28
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 28
- 229940010454 licorice Drugs 0.000 description 28
- 238000000605 extraction Methods 0.000 description 25
- 229940109850 royal jelly Drugs 0.000 description 21
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 241001092070 Eriobotrya Species 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 15
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- 239000002994 raw material Substances 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 229930014626 natural product Natural products 0.000 description 10
- 230000004156 Wnt signaling pathway Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 210000002615 epidermis Anatomy 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 210000002752 melanocyte Anatomy 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 244000060696 Alpinia speciosa Species 0.000 description 5
- 235000013411 Alpinia speciosa Nutrition 0.000 description 5
- 208000012641 Pigmentation disease Diseases 0.000 description 5
- 244000126002 Ziziphus vulgaris Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000019612 pigmentation Effects 0.000 description 5
- 241000256837 Apidae Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 4
- -1 for example Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 241000256844 Apis mellifera Species 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
- 244000061508 Eriobotrya japonica Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 229940127557 pharmaceutical product Drugs 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000001626 skin fibroblast Anatomy 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000013298 Alpinia <beetle> Species 0.000 description 2
- 241000256836 Apis Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 102000040739 Secretory proteins Human genes 0.000 description 2
- 108091058545 Secretory proteins Proteins 0.000 description 2
- 102000013814 Wnt Human genes 0.000 description 2
- 102000006757 Wnt Receptors Human genes 0.000 description 2
- 108010047118 Wnt Receptors Proteins 0.000 description 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 101710099518 Dickkopf-related protein 1 Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000007279 water homeostasis Effects 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015174214A JP6846106B2 (ja) | 2015-09-03 | 2015-09-03 | Ｄｋｋ１発現促進剤および美白剤 |
| JP2020026081A JP7402509B2 (ja) | 2015-09-03 | 2020-02-19 | Ｄｋｋ１発現促進剤および美白剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015174214A JP6846106B2 (ja) | 2015-09-03 | 2015-09-03 | Ｄｋｋ１発現促進剤および美白剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020026081A Division JP7402509B2 (ja) | 2015-09-03 | 2020-02-19 | Ｄｋｋ１発現促進剤および美白剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017048155A JP2017048155A (ja) | 2017-03-09 |
| JP2017048155A5 JP2017048155A5 (enExample) | 2018-09-13 |
| JP6846106B2 true JP6846106B2 (ja) | 2021-03-24 |
Family
ID=58279178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015174214A Active JP6846106B2 (ja) | 2015-09-03 | 2015-09-03 | Ｄｋｋ１発現促進剤および美白剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6846106B2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019182845A (ja) * | 2018-04-02 | 2019-10-24 | 学校法人藤田学園 | キヌレニンアミノトランスフェラーゼ２（ｋａｔ２）阻害剤 |
| JP7454355B2 (ja) * | 2018-12-27 | 2024-03-22 | ロート製薬株式会社 | Ｄｋｋ１産生促進剤及びその製造方法、ｄｋｋ１産生促進用美容組成物及びその製造方法、並びにｄｋｋ１産生促進方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07126149A (ja) * | 1993-10-28 | 1995-05-16 | Suntory Ltd | 美白用化粧料組成物 |
| JP2005029494A (ja) * | 2003-07-10 | 2005-02-03 | Fancl Corp | メラノサイト増殖抑制剤およびこれを含む化粧料 |
| JP2006008646A (ja) * | 2004-06-24 | 2006-01-12 | Eiji Yoda | 化粧料 |
| JP2008013481A (ja) * | 2006-07-05 | 2008-01-24 | Univ Of Tokushima | ゲットウ（Ａｌｐｉｎｉａｓｐｅｃｉｏｓａ）由来のチロシナーゼ活性阻害剤及びリポキシゲナーゼ活性阻害剤 |
| JP6029284B2 (ja) * | 2012-02-14 | 2016-11-24 | 一丸ファルコス株式会社 | キネシン抑制剤 |
| JP2014019683A (ja) * | 2012-07-23 | 2014-02-03 | Ichimaru Pharcos Co Ltd | メラニン含有ケラチノサイト分裂促進剤 |
-
2015
- 2015-09-03 JP JP2015174214A patent/JP6846106B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017048155A (ja) | 2017-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5137457B2 (ja) | 幹細胞増殖因子発現上昇抑制剤 | |
| JP2014221739A (ja) | Ｖｉｉ型コラーゲン発現促進剤 | |
| Park et al. | Nelumbo Nucifera leaf protects against UVB-induced wrinkle formation and loss of subcutaneous fat through suppression of MCP3, IL-6 and IL-8 expression | |
| JP6781549B2 (ja) | Ｅｎｄｏ１８０産生促進剤 | |
| JP2011001326A (ja) | エンドセリン−１ｍＲＮＡ発現抑制剤 | |
| KR102062854B1 (ko) | 복분자 뿌리의 활성분획물을 함유하는 화장료 조성물 | |
| JP6846106B2 (ja) | Ｄｋｋ１発現促進剤および美白剤 | |
| JP2011001328A (ja) | 塩基性線維芽細胞増殖因子ｍＲＮＡ発現上昇抑制剤 | |
| JP7402509B2 (ja) | Ｄｋｋ１発現促進剤および美白剤 | |
| JP6175216B2 (ja) | 関節炎の予防・治療剤 | |
| JP2010215571A (ja) | エンドセリン−１ｍＲＮＡ発現上昇抑制剤、塩基性線維芽細胞増殖因子ｍＲＮＡ発現上昇抑制剤及びプロオピオメラノコルチンｍＲＮＡ発現上昇抑制剤 | |
| JP2005239660A (ja) | 前駆脂肪細胞分化促進剤 | |
| JP6723979B2 (ja) | しわ改善剤 | |
| KR101310655B1 (ko) | 마름 추출물을 유효성분으로 포함하는 화장료 조성물 및 그 제조 방법 | |
| JP2022023250A (ja) | Ｄｋｋ１発現促進剤および美白剤 | |
| JP2015086168A (ja) | リパーゼ阻害剤および皮脂コントロール用皮膚化粧料 | |
| JP2002284648A (ja) | 育毛剤組成物 | |
| JP5896618B2 (ja) | メラニン産生抑制剤 | |
| JP2022078258A (ja) | エンドセリン変換酵素阻害剤 | |
| JP6017259B2 (ja) | エンドセリン作用抑制剤 | |
| JP7028803B2 (ja) | 美白剤 | |
| JP2014040487A (ja) | 脂肪蓄積抑制剤 | |
| JP2010215535A (ja) | メラニン産生抑制剤 | |
| JP2019182753A (ja) | Ｅｎｄｏ１８０産生促進剤 | |
| JP2019055924A (ja) | Ｅｎｄｏ１８０産生促進剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180803 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180803 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190424 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190507 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190705 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20191119 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200219 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20200219 |
|
| C11 | Written invitation by the commissioner to file amendments |
Free format text: JAPANESE INTERMEDIATE CODE: C11 Effective date: 20200303 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20200406 |
|
| C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20200407 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20200529 |
|
| C211 | Notice of termination of reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C211 Effective date: 20200602 |
|
| C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20201117 |
|
| C23 | Notice of termination of proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C23 Effective date: 20210126 |
|
| C03 | Trial/appeal decision taken |
Free format text: JAPANESE INTERMEDIATE CODE: C03 Effective date: 20210224 |
|
| C30A | Notification sent |
Free format text: JAPANESE INTERMEDIATE CODE: C3012 Effective date: 20210224 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210301 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6846106 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |